value After changing par value 1. Registered Capital 100,000,000.00 Baht 100,000,000.00 Baht 2. Paid up Capital 100,000,000.00 Baht 100,000,000.00 Baht 3. Par value 100.00 Baht/Share 0.50 Baht/Share 4
. million or . per cent, by the normal policy to improve the emolument for staff and executives. And , has expenses of the new Subsidiaries to support the growth of business continuity as mentioned. . Finance
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
decreasing due to the impact of COVID-19 outbreak, such preventive measures of social distancing and curfew. It caused the Group had to improve budget costs control in some projects. Such as increased costs of
-355.1 -5.0% Gross Profit 707.7 1,026.1 -318.4 -31.0% Gross Profit Margin (%) 9.5% 12.6% -3.1% SG&A expenses 459.9 440.4 19.5 4.4% Loss on exchange rate 0.0 35.4 -35.4 -100.0% EBIT before share of profit
investment decisions due to negative sentiment regarding Thailand's economic environment and slow government stimulus disbursement. However, Thai businesses continued to seek specific solutions to improve
Baht 2,896,834,342 to Baht 2,348,135,754 by cancelling 548,698,588 shares at a par value of Baht 1.00 per share. As such shares are the remaining shares which reserved for the existing shareholders by